Standard Biotools (LAB) Total Liabilities (2010 - 2026)

Standard Biotools (LAB) has 17 years of Total Liabilities data on file, last reported at $78.0 million in Q1 2026.

• On a quarterly basis, Total Liabilities fell 37.61% year-over-year to $78.0 million in Q1 2026; TTM through Mar 2026 was $78.0 million, a 37.61% decrease from a year earlier, with the FY2025 full-year figure at $143.5 million, up 2.02% from the prior year.
• Total Liabilities for Q1 2026 stood at $78.0 million, down from $143.5 million in the prior quarter.
• Over the last five years, Total Liabilities for LAB reached as high as $249.8 million in Q1 2022 and fell as low as $78.0 million in Q1 2026.
• Historically, Total Liabilities has averaged $160.6 million across 5 years, with a median of $159.8 million in 2023.
• Across the five-year window, Total Liabilities soared 37.07% in 2022 and sank 37.61% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $160.5 million in 2022, then declined by 0.41% to $159.9 million in 2023, then slipped by 12.04% to $140.6 million in 2024, then gained by 2.02% to $143.5 million in 2025, then sank by 45.64% to $78.0 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $78.0 million in Q1 2026, $143.5 million in Q4 2025, and $140.0 million in Q3 2025.